Molecular Therapy: Nucleic Acids (Sep 2024)

Endothelial derived, secreted long non-coding RNAs Gadlor1 and Gadlor2 aggravate cardiac remodeling

  • Merve Keles,
  • Steve Grein,
  • Natali Froese,
  • Dagmar Wirth,
  • Felix A. Trogisch,
  • Rhys Wardman,
  • Shruthi Hemanna,
  • Nina Weinzierl,
  • Philipp-Sebastian Koch,
  • Stefanie Uhlig,
  • Santosh Lomada,
  • Gesine M. Dittrich,
  • Malgorzata Szaroszyk,
  • Ricarda Haustein,
  • Jan Hegermann,
  • Abel Martin-Garrido,
  • Johann Bauersachs,
  • Derk Frank,
  • Norbert Frey,
  • Karen Bieback,
  • Julio Cordero,
  • Gergana Dobreva,
  • Thomas Wieland,
  • Joerg Heineke

Journal volume & issue
Vol. 35, no. 3
p. 102306

Abstract

Read online

Pathological cardiac remodeling predisposes individuals to developing heart failure. Here, we investigated two co-regulated long non-coding RNAs (lncRNAs), termed Gadlor1 and Gadlor2, which are upregulated in failing hearts of patients and mice. Cardiac overexpression of Gadlor1 and Gadlor2 aggravated myocardial dysfunction and enhanced hypertrophic and fibrotic remodeling in mice exposed to pressure overload. Compound Gadlor1/2 knockout (KO) mice showed markedly reduced myocardial hypertrophy, fibrosis, and dysfunction, while exhibiting increased angiogenesis during short and prolonged periods of pressure overload. Paradoxically, Gadlor1/2 KO mice suffered from sudden death during prolonged overload, possibly due to cardiac arrhythmia. Gadlor1 and Gadlor2, which are mainly expressed in endothelial cells (ECs) in the heart, where they inhibit pro-angiogenic gene expression, are strongly secreted within extracellular vesicles (EVs). These EVs transfer Gadlor lncRNAs to cardiomyocytes, where they bind and activate calmodulin-dependent kinase II, and impact pro-hypertrophic gene expression and calcium homeostasis. Therefore, we reveal a crucial lncRNA-based mechanism of EC-cardiomyocyte crosstalk during heart failure, which could be specifically modified in the future for therapeutic purposes.

Keywords